Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05765006Phase 1Unknown
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 2023-02-24

Research Network

Collaboration Network

18 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Renji Hospital Shanghai Jiaotong University School of Medical

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xianyun Wang, Doctor

The First Hospital of Hebei Medical University

Moderately Similar
4 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
7 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Veronique Leguern, MD

Service de Médecine Interne, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 PARIS Cedex 14.

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Luc Mouthon, MD

Service de Médecine Interne, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 PARIS Cedex 14. Email: luc.mouthon@cch.aphp.fr

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Colleen Annesley, MD

Seattle Children's Hospital

Moderately Similar
7 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Michelle Petri, MD

Dept of Rheumatology, 1830 Building, Suite 7500. Email: mpetri@jhmi.edu

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Loïc Guillevin, MD

Service de Médecine Interne, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75679 PARIS Cedex 14. Email: loic.guillevin@wanadoo.fr

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

xiaofeng zeng

Peking Union Medical College Hospital

Moderately Similar
10 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Similarity Score30%

Ronald F. van Vollenhoven, MD

Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska University Hospital, D10:0, Department of Rheumatology, 17176 Stockholm, Sweden. Email: Ronald.van.Vollenhoven@ki.se

Moderately Similar
1 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05765006Phase 1PrincipalInvestigator

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Unknown

All 1 trials loaded